UPDATE: Auxilium Posts Upbeat Q3 Profit
November 06, 2013 at 09:28 AM EST
Auxilium Pharmaceuticals (NASDAQ: AUXL ) reported an upbeat third-quarter profit and narrowed its revenue outlook for the full year. Auxilium now projects full-year revenue of $370 million to $401 million, versus its prior forecast of $363 million to $405 million. Auxilium posted a quarterly net loss of $28.9 million, or $0.59
